223 related articles for article (PubMed ID: 19778527)
21. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
22. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.
Schroers R; Baraniskin A; Heute C; Kuhnhenn J; Alekseyev A; Schmiegel W; Schlegel U; Pels HJ
Eur J Haematol; 2010 Sep; 85(3):236-42. PubMed ID: 20528903
[TBL] [Abstract][Full Text] [Related]
23. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
24. The evolving use of serum free light chain assays in haematology.
Pratt G
Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
26. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
28. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
29. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G
Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852
[TBL] [Abstract][Full Text] [Related]
30. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
31. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
32. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
33. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
[TBL] [Abstract][Full Text] [Related]
34. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
[TBL] [Abstract][Full Text] [Related]
35. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
38. [Progress in the management of multiple myeloma introduced by serum free light chain measurement].
Fuchida S; Shimazaki C
Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331
[TBL] [Abstract][Full Text] [Related]
39. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
40. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
